CDKN2A and neoplasm: To investigate whether senescence was involved in p16INK4A -mediated tumor suppression in KRAS4AG12V tumors, Western blotting was performed using antibodies against heterochromatin protein 1 gamma (HP1γ) and decoy receptor 2 (DCR2), molecular markers for senescence [31].